David Nicholas Gee, Chief Marketing Officer of Cellebrite DI Ltd., filed a Form 4 on November 13, 2026, disclosing the sale of 234 ordinary shares on November 12, 2026, in connection with tax obligations arising from the vesting of restricted stock units.
Key Highlights
- Reporting person: David Nicholas Gee, Chief Marketing Officer of Cellebrite DI Ltd. (NASDAQ:CLBT)
- Transaction date: November 12, 2026 - disposition of 234 ordinary shares, par value NIS 0.00001
- Transaction code: S (sale), with shares disposed of at a weighted average price of $13.3103
- Price range: Individual sale prices ranged from $12.93 to $13.57, inclusive, across multiple transactions
- RSU origin: The disposed shares were granted on February 11, 2025 as restricted stock units, with the disposition associated with tax obligations upon vesting
- Remaining holdings: 135,047 ordinary shares beneficially owned directly following the reported transaction
Cellebrite CMO's RSU Vesting Triggers Tax-Related Share Sale
According to the Form 4 filed with the U.S. Securities and Exchange Commission, David Nicholas Gee, serving as Chief Marketing Officer of Cellebrite DI Ltd. (NASDAQ:CLBT), disposed of 234 ordinary shares on November 12, 2026. The filing identifies the transaction code as S and states that the shares were sold across multiple transactions at prices ranging from $12.93 to $13.57, inclusive, with a weighted average price of $13.3103 reported in the filing.
The filing's explanation of responses states that the disposed shares "were granted on February 11, 2025, in the form of restricted stock units" and that "the disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs." Gee's address is listed as 94 Shlomo Shmelzer Road, Petah Tikva, Israel. The filing was signed by David Nicholas Gee and dated November 13, 2026.
Following the reported transaction, the filing discloses that Gee directly holds 135,047 ordinary shares. No derivative securities transactions were reported in Table II of the filing. The filing notes that Gee undertakes to provide full information regarding the number of shares sold at each separate price within the stated range upon request by the issuer, any security holder, or SEC staff.
What Was Disclosed
Cellebrite DI Ltd.'s Chief Marketing Officer David Nicholas Gee reported the sale of 234 ordinary shares on November 12, 2026, tied to RSU vesting tax obligations, at a weighted average price of $13.3103, leaving him with 135,047 directly held shares.




Please wait processing your request...